CytomX Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VR ADVISER, LLC | 11/14/2025 | 15.56 M | $49.64 M | 11.39% | 9.43% |
| FMR LLC | 11/13/2025 | 15.40 M | $49.11 M | 66.65% | 9.33% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 11.07 M | $35.30 M | 0.00% | 6.71% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 9.68 M | $30.88 M | 38.41% | 5.87% |
| VANGUARD GROUP INC | 11/07/2025 | 8.95 M | $28.54 M | -4.61% | 5.42% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 8.46 M | $26.99 M | 0.00% | 5.13% |
| COMMODORE CAPITAL LP | 11/14/2025 | 7.69 M | $24.54 M | 0.00% | 4.66% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 4.25 M | $13.56 M | 22.00% | 2.58% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 4.07 M | $12.98 M | -49.68% | 2.47% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 4.05 M | $12.90 M | 31.28% | 2.45% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 3.91 M | $12.48 M | 36.55% | 2.37% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 3.65 M | $11.63 M | 69.26% | 2.21% |
| RTW INVESTMENTS, LP | 11/14/2025 | 3.46 M | $11.04 M | 0.00% | 2.10% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 3.37 M | $10.76 M | 100.00% | 2.04% |
| VIVO CAPITAL, LLC | 11/14/2025 | 2.88 M | $9.20 M | -50.00% | 1.75% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 2.66 M | $8.49 M | 0.00% | 1.61% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 2.55 M | $8.12 M | 36.68% | 1.54% |
| BLACKROCK, INC. | 11/12/2025 | 2.38 M | $7.60 M | -0.27% | 1.44% |
| WOODLINE PARTNERS LP | 11/14/2025 | 2.34 M | $7.46 M | 0.00% | 1.42% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.80 M | $5.74 M | 2,005.55% | 1.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.57 M | $5.01 M | -10.08% | 0.95% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.39 M | $4.42 M | 494.36% | 0.84% |
| FINANCIAL ENGINES ADVISORS L.L.C. | 11/17/2025 | 1.38 M | $4.41 M | 100.00% | 0.84% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 1.24 M | $3.95 M | 100.00% | 0.75% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.10 M | $3.52 M | -53.04% | 0.67% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.01 M | $3.21 M | 20,969.55% | 0.61% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 900.00 K | $2.87 M | 100.00% | 0.55% |
| EXOME ASSET MANAGEMENT LLC | 11/14/2025 | 745.31 K | $2.38 M | 100.00% | 0.45% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 729.97 K | $2.33 M | 1.38% | 0.44% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 729.70 K | $2.33 M | 362.77% | 0.44% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 653.73 K | $2.08 M | -58.01% | 0.40% |
| STATE STREET CORP | 11/14/2025 | 644.98 K | $2.06 M | 0.93% | 0.39% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 564.80 K | $1.80 M | -83.94% | 0.34% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 535.97 K | $1.71 M | -15.03% | 0.32% |
| INSPIRE INVESTING, LLC | 10/15/2025 | 522.48 K | $1.67 M | 100.00% | 0.32% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 451.13 K | $1.44 M | 146.29% | 0.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 447.75 K | $1.43 M | 2,950.50% | 0.27% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 401.89 K | $1.28 M | 100.00% | 0.24% |
| JANE STREET GROUP, LLC | 11/14/2025 | 401.37 K | $1.28 M | 3,253.67% | 0.24% |
| NORTHERN TRUST CORP | 11/14/2025 | 389.69 K | $1.24 M | -13.42% | 0.24% |
| MORGAN STANLEY | 11/14/2025 | 319.29 K | $1.02 M | -5.87% | 0.19% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 293.56 K | $936.46 K | 3.53% | 0.18% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 267.49 K | $853.28 K | -8.36% | 0.16% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 257.15 K | $820.30 K | 100.00% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 252.66 K | $805.98 K | 0.00% | 0.15% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 249.90 K | $797.18 K | 233.20% | 0.15% |
| PRECISION WEALTH STRATEGIES, LLC | 10/16/2025 | 237.08 K | $756.29 K | 100.00% | 0.14% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 206.53 K | $658.82 K | 100.00% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 201.80 K | $643.74 K | 1,254.36% | 0.12% |
| DIADEMA PARTNERS LP | 11/14/2025 | 185.29 K | $591.06 K | 100.00% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 143 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
VR Adviser, LLC: 15.56 M
FMR LLC: 15.4 M
TANG CAPITAL MANAGEMENT LLC: 11.07 M
PERCEPTIVE ADVISORS LLC: 9.68 M
VANGUARD GROUP INC: 8.95 M
ORBIMED ADVISORS LLC: 8.46 M
83.32% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 141.37 M shares in the last 24 months. This purchase volume represents approximately $466.53 M in transactions.